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ABSTRACT 
The use of liposomes as drug delivery vehicle for treatment of various diseases is well known in medical field but its possible role as 
a masking agent in sports came into light when Liposom Forte® was found stored together with banned and non-banned drugs 
during investigations carried out by Italian legal authorities and recent availability of IGF-1 Liposomal Spray on internet. Role of 
liposomes as masking agent for anabolic steroids in the field of doping has been investigated by Botre et al. The aim of the present 
work was to study the effect of different parameters like temperature, pH, charge, time, concentration etc. on the interaction of 
liposomes and doping agents and to identify a possible marker for detection of their abuse in sports. The results showed that out of 
variety of doping agents, the direct addition of liposomes to urine samples containing anabolic steroids shows strong tendency to 
interact with the liposomes which results in the reduced concentration of the compound in the sample. However, there was no 
significant effect of temperature and incubation time on the interaction of liposome and doping agents while other parameters such 
as charge and concentration of liposome affect the interaction capacity.  
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INTRODUCTION: 
Liposomes are self-assembled lipoidal vesicles used for 
encapsulation of drugs in drug delivery system. The 
hydrophobic drugs intercalate in between lipid bilayer 
while hydrophilic drugs encapsulated in aqueous core 
of the liposome.  This property of liposomes could be 
misused by athletes to alter the concentration of drugs 
in urine sample when liposomes were added externally 
in urine at the time of sample collection. The concept of 
interaction between liposome and anabolic steroids has 
been studied and reported by Botre et al
1, 2
. The present 
work aimed to ascertain the effect of various 
parameters on in-vitro interaction of liposomes with 
various threshold and non-threshold substances 
prohibited in sports; and secondly to identify a possible 
marker for the detection of liposome abuse. 
MATERIALS AND METHOD:  
 Reagents and Chemicals 
Reference standards were obtained from Sigma-
Aldrich, USA, and National Measurement Institute 
(NMI), Australia.  Empty liposomes [Coatsomes EL 
Series: EL-01-A (Anionic ( DPPC: Cholesterol: 
DPPG=30:40:30 μmol/vial)), EL-01-C (Cationic 
(DPPC: Cholesterol: Stearylamine=52:40:8 μmol/vial)) 
and EL-01-N (Neutral(DPPC: Cholesterol: 
DPPG=54:40:6 μmol/vial  ))] from Nippon Oil & Fats 
Co., Ltd (NOF) (Tokyo, Japan), β- Glucuronidase from 
E. coli (Roche Diagnostics, USA) and  other reagents, 
solvents of HPLC or analytical grade were procured.  
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Experimental Design 
Each vial of freeze dried liposomes was reconstituted 
as per manufacturer’s specification. Interaction of 
liposomes was studied with approximately 120 WADA 
Prohibited Drugs. Out of 120 drugs, 5 threshold 
compounds (19-Norandrosterone, 19-
Noretiocholanolone, Morphine, Salbutamol, Carboxy-
Tetrahydrocannabinol) and 6 endogenous steroids 
(Androsterone, Etiocholanolone, Testosterone, 
Epitestosterone, 5α-androstane-3α,17β-diol (5α-diol), 
5β-androstane-3α,17β-diol (5β-diol)) were selected  to 
ascertain effect of various parameters i.e. concentration, 
pH, time, temperature on the interaction efficiency of 
liposomes. To study the effect of concentration of 
liposomes on binding efficiency with various 
compounds, five different volumes (10-100 μl) of 
reconstituted liposomes of different types (anionic, 
cationic and neutral liposomes) were added to urine 
samples spiked with drugs at threshold level. To 
determine the effect of pH (pH 5, 7, and 9), time of 
interaction (24 & 48 hrs) and operating temperature (4 
0
C, 37 
0
C & room temperature (RT 25±2)), compounds 
were spiked in urine at their threshold level, 40 μl of 
reconstituted liposome of different ionic strength was 
added in each sample. Entire experiments were 
repeated for five consecutive days. Post reaction 
samples were screened using in house extraction 
procedure for anabolic steroids and analysed on Gas 
Chromatography-Mass Spectrometry (GC-MSD)
 3
. 
Monitoring of Cholesterol   
Cholesterol was incorporated in routine method duly 
validated for quantification. Concentration of 
cholesterol was measured in 1000 routine samples and 
samples of liposome interaction experiments. 
Data Analysis 
With each experiment one spiked sample was prepared 
and analyzed without addition of liposomes. Recovery 
of target compounds was calculated by peak area ratios 
of each analyte to internal standard.  
RESULT AND DISCUSSION:  
Interaction of Liposomes with drugs: 
Out of variety of doping agents, the direct addition of 
liposomes to urine samples containing anabolic steroids 
showed strong tendency to interact which results in the 
reduced concentration of compound in the sample.  
Effect of Concentration of liposomes on binding 
efficiency:
 
 
Figure 1: Effect of increasing concentration of reconstituted liposomes (10-100 µl) (1A-Anionic, 1B-Cationic, 1C-
Neutral) on recovery of various drugs 
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The recovery of various drugs in urine decreased with 
increasing concentration of liposomes in the urine. Out 
of three different formulations of liposomes, anionic 
showed maximum binding capacity with doping 
agents. However, anabolic steroids showed maximum 
tendency to interact with liposomes as most of the 
steroids are derivatives of cholesterol. The interaction 
of other drugs like morphine, salbutamol and Carboxy-
Tetrahydrocannabinol (THC) with liposomes was 
minimal. (Fig. 1).  
Effect of pH on binding efficiency: 
Results of urine samples having different pH (5, 7 and 
9) spiked with reconstituted liposome (40 μl) and drugs 
revealed that basic pH facilitated the interaction as 
recovery of steroids was  5 to 10 % less in basic pH as 
compared to neutral or acidic pH. Significance of data 
was calculated by statistical analysis using SPSS 16.0 
by applying one-way analysis of variance with post-
hoc Bonferroni analysis. P value observed was .001 
which is below P<0.05, hence considered as 
significant. 
Effect of incubation temperature and time on 
binding efficiency: 
No significant effect of Temperature and time on the 
binding efficiency of liposomes with doping agents 
was observed  
 
 
Figure 2(1): Effect of pH on interaction of liposomes (1A-Anionic, 1B-Cationic, 1C-Neutral) with various doping agents 
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Figure 2(2): Effect of Temperature on interaction of liposomes (2A-Anionic, 2B-Cationic, 2C-Neutral) with various doping agents 
 
Figure 2(3): Effect of Incubation time on interaction of liposomes (3A-Anionic, 3B-Cationic, 3C-Neutral) with various doping 
agents 
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Cholesterol: Possible marker for liposome abuse 
It has been reported that cholesterol is main ingredient 
of liposome. It was assumed that during interaction of 
liposomes with various drugs, cholesterol should be 
released. Cholesterol is an endogenous compound and 
excreted in urine. Its concentration might be increased in 
various physiological concentration. The concentration 
of cholesterol was monitored in routine dope samples 
(n=1000) and was found to be in the range of 45 ng/ml 
to 376 ng/ml (Fig-3). The concentrations of cholesterol 
were verified on each vial of liposomes used in the 
study by direct liposome analysis and during the 
experiments liposomes were spiked in urine at a 
concentration of 15µg/ml of cholesterol. Concentration 
of cholesterol was quantified in blank urine (n=5) and 
urine spiked with different formulations of liposomes. 
Results revealed that the concentration of cholesterol 
increased 4 to 5 folds when same urine samples were 
spiked with liposome (Fig. 3). The result of this 
preliminary study postulate that detection of cholesterol 
in routine doping sample can act as marker for abuse of 
liposome as masking agent. 
 
 
Figure 3a: Concentration of cholesterol in routine dope testing samples (n=1000)  
 
 
Figure 3b: Effect of liposomes on the urinary concentration of cholestrol 
 
CONCLUSION:  
This study reveals that liposome have the ability to 
mask different classes of drug in the urine matrix. 
However, androgenic anabolic steroids showed strong 
affinity towards liposomes when added in urine. The 
masking of drugs with liposome is proportional to the 
concentration of liposome added in the sample. 
Elevated pH (pH 9) facilitated interaction of liposomes 
with all classes of drugs studied in the present work. 
Cholesterol seems to be a potential marker of 
liposomes abuse with elevated level recovers in urine 
spiked with liposomes. However, Cholesterol is 
endogenously produced and may be a by-product of 
various physiological conditions therefore an extensive 
profiling of cholesterol threshold value should be 
established to be used as direct marker of liposome 
use. 
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